Close Menu

NEW YORK – A team of German researchers in collaboration with Qiagen has built a workflow to analyze genomic and transcriptomic data in parallel from multiple analytes including circulating tumor cells (CTCs), circulating cell-free tumor DNA (cfDNA), and extracellular vesicles (EVs) from a minimal blood volume sample.

The team has now begun analyzing additional analytes in HER2-positive breast cancer patients and will present preliminary results at the American Association of Cancer Research Meeting in May.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.